BREAKING
Home » Posts Tagged "ZMapp"

CDC Lab Research Shows Two Treatments Effective Against DRC Ebola Strain

By

New research by the Centers for Disease Control and Prevention (CDC) shows two investigational Ebola treatments being used in the ongoing outbreak in eastern Democratic Republic of the Congo (DRC) are...

DRC map

DR Congo approves four new Ebola treatments to contain outbreak

By

The Democratic Republic of Congo has approved the use of four experimental Ebola treatments to manage the ongoing outbreak in the east of the country. At least 59 people have died, with 102 cases diagnosed...

Broadly neutralizing antibodies found in the blood of Ebola survivors: Study

By

Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments...

Hungary: Scientist accidentally exposed to Ebola while in the laboratory; No symptoms to date

By

In a follow-up to a news report on a Hungarian scientist who was accidentally exposed to Ebola virus,  health authorities (computer translated) say the scientist was exposed on April 13  at the National...

ZMapp antibody delivered by viral vector protects against Ebola infection

By

A new study comparing the effectiveness of individual ZMapp antibodies versus a cocktail of antibodies, administered to mice using recombinant adeno-associated virus (rAAV) delivery vectors, showed the...

How ZMapp targets Ebola virus: The Scripps Research Institute study

By

Scientists at The Scripps Research Institute (TSRI) now have a high-resolution view of exactly how the experimental therapy ZMapp targets Ebola virus. The new study is also the first to show how an antibody...

Ebola drug, ZMapp, gets FDA Fast Track Status

By

LeafBio, Inc. (LeafBio), the commercial arm of Mapp Biopharmaceutical, Inc. (Mapp), announced last week that the U.S. Food and Drug Administration (FDA) has granted ZMapp™ “Fast Track” designation...

Mapp Biopharmaceutical to make ZMapp Ebola treatment for Canada

By

The Honourable Rona Ambrose, Minister of Health, and Canada’s Chief Public Health Officer, Dr. Gregory Taylor, yesterday announced a $4.5 million USD contract between the Government of Canada and...

US government contracts with Mapp Biopharmaceutical to get ZMapp to FDA approval

By

The development of a medication to treat illness from Ebola will be accelerated under a contract with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness...

Ebola cases near 2,000, available supply of ZMapp ‘has been exhausted’

By

The number of Ebola Virus Disease (EVD) cases and fatalities continued to climb on 10 and 11 August 2014, according to the World Health Organization (WHO) today. A total of 128 new cases of Ebola virus...